Director and Executive Officer Incentives Through Stock Compensation-Type Stock Acquisition Rights
First written in FY2017. 5 of 10 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2025.
The whole theme swung hardest in 2024: 4 of 27 companies on the "Worse" side.
20 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Treasury shares decreased by 7,800 shares as a result of the disposal carried out on 7 February 2025 as restricted stock compensation.」
Under the restricted stock compensation program transitioned from stock acquisition rights, the Company granted and disposed of 7,800 shares in February 2025. - FY2023RestatedAnnual report
「Treasury shares decreased by 9,000 shares as a result of the disposal carried out on 10 February 2023 as restricted stock compensation.」
The Company has continued operating the restricted stock compensation program introduced in place of stock acquisition rights, disposing of 9,000 shares in February 2023. - FY2022-Q2AdvancedAnnual report
「Treasury shares decreased by 9,000 shares as a result of their disposal as restricted stock compensation on 10 February 2022.」
Under the stock-based compensation program changed from stock acquisition rights to restricted stock compensation, the Company disposed of 9,000 treasury shares. - FY2021ReframedAnnual report
「At the 76th Annual General Meeting of Shareholders held on 17 December 2020, the Company resolved, separately from and in addition to the above compensation limits for directors and excluding outside directors, to introduce a restricted stock compensation program with an annual amount of no more than ¥50 million and a total annual limit of 5,000 common shares. The program replaced the former stock-compensation-type stock acquisition rights program. With its introduction, the Company discontinued new grants under the former program and has not issued any further stock acquisition rights as stock-compensation-type stock acquisition rights.」
The Company changed its stock-based compensation program for directors and executive officers from new grants of stock acquisition rights to a restricted stock compensation program. - FY2021-Q2Implementing Restricted Stock CompensationAnnual report
「Treasury shares decreased by 4,050 shares as a result of their disposal as restricted stock compensation on 12 February 2021.」
The Company stated that it had disposed of treasury shares as restricted stock compensation, separately from the existing stock acquisition rights. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Based on the resolution of 17 December 2019, the Company issued 427 stock acquisition rights, representing 4,270 underlying shares, to 5 directors and 9 executive officers on 14 January 2020. - FY2019-Q2RestatedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
The Company restated the issuance terms for 414 stock acquisition rights, representing 4,140 underlying shares, to 4 directors and 12 executive officers. - FY2018AdvancedAnnual report
「Board of Directors Resolution date: 18 December 2018 Company directors: 4 Company executive officers: 12 Number of stock acquisition rights: 414 Class, description and number of underlying shares: common shares, 4,140」
The Company disclosed a resolution to issue 414 stock acquisition rights, representing 4,140 shares, corresponding to Series 8, following the Series 7 grant of 226 rights and 2,260 shares under the stock-compensation-type stock acquisition rights program. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: Number of stock acquisition rights: 226; number of underlying shares: 2,260.」
During the second quarter accounting period, the Company issued 226 stock acquisition rights, representing 2,260 underlying shares, under the stock-compensation-type stock acquisition rights approved in the previous fiscal year. - FY2017First statedAnnual report
「At a meeting of the Board of Directors held on 19 December 2017, the Company resolved the terms of the offering of stock acquisition rights to be issued to its directors as follows.」
The Company disclosed a resolution to allot 226 Series 7 stock-compensation-type stock acquisition rights, representing 2,260 underlying shares, to 4 directors and 11 executive officers on 15 January 2018.